ARCHIVES

In Brief: FDA’s Tabor To Head Biological Carcinogenesis in DCE; Steve Larson to Leave NIH for Memorial

This article is from The Cancer Letter archive.

Vol. 14 No. 18 | April 29, 1988

Download PDF Visit The Full Archive

Related Articles

FDA, NCI, Congress Shape Pediatric Drug Development Proposals

April 11, 2003

In Brief: NCAB To Protest Tobacco Ads In ‘Family Circle’; ACS Petitions For Taxol Source Designation

October 19, 1990

Klausner To Revamp NCI Budget Process To Make Categories Mean What They Say

December 8, 1995

Bush Budget Proposal a $511 Million Cut For NIH.

February 9, 2007

In Brief: FDA Names DeLap Directory Of Oncology

June 7, 1996

In Brief: Masnyk Named DCBD Deputy Director Maizel to Head NCI’s “Supercomputer” Development

November 2, 1984